Median survival for 49 AFP-detected HCC was 729 days post-diagnosis compared to 1043 days in 61 patients with US-detected HCC, but the difference in survival was not statistically significant (Fig 1d). The gene discussed is AFP; the disease is hepatocellular carcinoma.